FOLH1 and prostate cancer: Queries combined prostate cancer with AI, machine learning, radiomics, pathomics, PSA, MRI, transrectal ultrasound (TRUS), prostate-specific membrane antigen (PSMA) PET/CT, biopsy, radiotherapy planning, and focal therapies.